{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/08/3269975/0/en/BioXcel-Therapeutics-Announces-Enrollment-of-First-Patients-in-U-S-Department-of-War-Funded-Study-of-BXCL501-Sublingual-Dexmedetomidine-for-Treatment-of-Acute-Stress-Reactions.html", "message": "News view counter 653086 successfully enlarged"}